Interrelationships of factor VII activity and plasma leptin with insulin resistance in coronary heart disease



      An increase of FVII activity (FVIIc) has been proposed to be an independent cardiovascular risk factor. Whether FVII is associated with insulin resistance in coronary heart disease (CHD) is still unknown. We tested the hypothesis that plasma FVII activity and leptin are associated with insulin resistance independently.


      We studied 130 subjects, of which 65 were CHD subjects and 65 were non-CHD control subjects. Fasting plasma levels of leptin, insulin, glucose, FVIIc activity, fibrinogen, lipid parameters were estimated for all the subjects. Body mass index (BMI), waist circumference (WC) and blood pressure levels were also determined.


      We observed significantly raised plasma levels of FVIIc activity, leptin and insulin resistance among the CHD subjects compared to the non-CHD subjects. Raised FVIIc activity levels in CHD were significantly positively correlated with insulin resistance. Raised plasma leptin levels in CHD were correlated with insulin resistance, BMI and WC. Multivariate regression analysis showed that elevated levels of FVII activity in CHD was significantly associated with insulin resistance, independent of dyslipidemia, leptin, blood pressure levels, BMI, WC, gender and age. Furthermore, raised leptin levels in CHD subjects were significantly associated with insulin resistance and BMI, independently of each other and of dyslipidemia, FVIIc, blood pressure levels, WC, gender and age.


      Raised FVII and leptin levels in CHD patients were independently associated with insulin resistance, this was not observed among the non-CHD subjects.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • DeWood M.
        • Spores J.
        • Notske R.
        • et al.
        Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction.
        N Engl J Med. 1980; 303: 897-902
        • Meade T.W.
        • Mellows S.
        • Brozovic M.
        • et al.
        Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.
        Lancet. 1986; 2: 533-537
        • Suzuki T.
        • Yamauchi K.
        • Matsushita T.
        • et al.
        Elevation of factor VII activity and mass in coronary artery disease of varying severity.
        Clin Cardiol. 1991; 14: 731-736
        • Broadhurst P.
        • Kelleher C.
        • Hughes L.
        • Imeson J.D.
        • Raftery E.B.
        Fibrinogen, factor VII clotting activity and coronary artery disease severity.
        Atherosclerosis. 1990; 85: 169-173
        • Hoffman C.J.
        • Miller R.H.
        • Lawson W.E.
        • Hultin M.B.
        Elevation of factor VII activity and mass in young adults at risk of ischemic heart disease.
        J Am Coll Cardiol. 1989; 14: 941-946
        • Wu K.K.
        • Folsom A.R.
        • Heiss G.
        • et al.
        Association of coagulation factors and inhibitors with carotid artery atherosclerosis: early results of the ARIC study.
        Ann Epidemiol. 1992; 2: 471-480
        • Folsom A.R.
        • Wu K.K.
        • Rosamond W.D.
        • Sharrett A.R.
        • Chambless L.E.
        A prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study.
        Circulation. 1997; 96: 1102-1108
        • Heinrich J.
        • Balleisen L.
        • Schulte H.
        • Assmann G.
        • van de Loo J.
        Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men.
        Arterioscler Thromb. 1994; 14: 54-59
        • Folsom A.R.
        • Wu K.K.
        • Davis C.E.
        • et al.
        Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors.
        Atherosclerosis. 1991; 91: 191-205
        • Reaven G.M.
        The role of insulin resistance and hyperinsulinemia in coronary heart disease.
        Metabolism. 1992; 41: 16-19
        • Kamohara S.
        • Burcelin R.
        • Halaas J.L.
        • Friedman J.M.
        • Charron M.J.
        Acute stimulation of glucose metabolism in mice by leptin treatment.
        Nature. 1997; 389: 374-377
        • Mantzoros C.S.
        The role of leptin in human obesity and disease: a review of current evidence.
        Ann Intern Med. 1999; 130: 671-680
        • Soderberg S.
        • Ahren B.
        • Jansson J.H.
        • et al.
        Leptin is associated with increased risk of myocardial infarction.
        J Intern Med. 1999; 246: 409-418
        • Wallace A.M.
        • McMahon A.D.
        • Packard C.J.
        • et al.
        Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).
        Circulation. 2001; 104: 3052-3056
        • DeFronzo R.A.
        • Ferrannini E.
        Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.
        Diabetes Care. 1991; 14: 173-194
        • Matthews D.R.
        • Hosker J.P.
        • Rudenski A.S.
        • et al.
        Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
        Diabetologia. 1985; 28: 412-419
        • Mertens I.
        • Gaal F.V.
        Obesity, haemostasis and the fibrinolytic system.
        Obes Rev. 2002; 3: 85-101
        • Lowe G.D.O.
        • Rumley A.
        • Wannamethee S.G.
        Hemostatic abnormalities associated with obesity and the metabolic syndrome.
        J Thromb Haemost. 2005; 3: 1076-1078
        • Wannamethee S.G.
        • Lowe G.D.
        • Shaper A.G.
        • et al.
        The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men.
        Atherosclerosis. 2005; 181: 101-108
        • Segal K.R.
        • Landt M.
        • Klein S.
        Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men.
        Diabetes. 1996; 45: 988-991
        • Donahue R.P.
        • Zimmet P.
        • Bean J.A.
        • et al.
        Cigarette smoking, alcohol use, and physical activity in relation to serum leptin levels in a multiethnic population: The Miami Community Health Study.
        Ann Epidemiol. 1999; 9: 108-113
        • Kieffer T.J.
        • Heller R.S.
        • Habaner J.F.
        Leptin receptors expressed on pancreatic b-cells.
        Biochem Biophys Res Commun. 1996; 224: 522-527
        • Margetic S.
        • Gazzola C.
        • Pegg C.G.
        • Hill R.A.
        Leptin: a review of its peripheral actions and interactions.
        Int J Obes. 2002; 26: 1407-1433
        • Wannamethee S.G.
        • Tchernova J.
        • Whincup P.
        • et al.
        Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease.
        Atherosclerosis. 2007; 191: 418-426
        • Kain K.
        • Catto A.J.
        • Grant P.J.
        Associations between insulin resistance and thrombotic risk factors in high-risk South Asian subjects.
        Diabet Med. 2003; 20: 651-655
        • Godsland I.F.
        • Crook D.
        • Proudler A.J.
        • Stevenson J.C.
        Hemostatic risk factors and insulin sensitivity, regional body fat distribution, and the metabolic syndrome.
        J Clin Endocrinol Metab. 2005; 90: 190-197
        • Romano M.
        • Guagnano M.T.
        • Pacini G.
        • et al.
        Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women.
        J Clin Endocrinol Metab. 2003; 88: 5321-5326
        • Cooke J.P.
        • Oka R.K.
        Does leptin cause vascular disease?.
        Circulation. 2002; 106: 1904-1905
        • Juhan-Vague I.
        • Alessi M.C.
        • Mavri A.
        • et al.
        Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk.
        J Thromb Haemost. 2003; 1: 1575-1579
        • Toschi V.
        • Gallo R.
        • Lettino M.
        • et al.
        Tissue factor modulates the thrombogenicity of human atherosclerotic plaques.
        Circulation. 1997; 95: 594-599